BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
13 results:

  • 1. Akt-Activated Endothelium Increases cancer Cell Proliferation and Resistance to Treatment in ovarian cancer Cell Organoids.
    Hoarau-Véchot J; Blot-Dupin M; Pauly L; Touboul C; Rafii S; Rafii A; Pasquier J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430649
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic cancer Early Detection.
    Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
    Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on ovarian cancer Progression.
    Escalona RM; Chan E; Kannourakis G; Findlay JK; Ahmed N
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393911
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Plasma levels of MMP-7 and timp-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
    Będkowska GE; Gacuta E; Zajkowska M; Głażewska EK; Osada J; Szmitkowski M; Chrostek L; Dąbrowska M; Ławicki S
    J Ovarian Res; 2017 Jun; 10(1):39. PubMed ID: 28662671
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation in pre-diagnosis samples discounts ICAM-1 and timp-1 as biomarkers for earlier diagnosis of pancreatic cancer.
    Jenkinson C; Elliott V; Menon U; Apostolidou S; Fourkala OE; Gentry-Maharaj A; Pereira SP; Jacobs I; Cox TF; Greenhalf W; Timms JF; Sutton R; Neoptolemos JP; Costello E
    J Proteomics; 2015 Jan; 113():400-2. PubMed ID: 25316052
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays.
    Jiang W; Huang R; Duan C; Fu L; Xi Y; Yang Y; Yang WM; Yang D; Yang DH; Huang RP
    PLoS One; 2013; 8(10):e76795. PubMed ID: 24116163
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications].
    Stettner R; Bogusiewicz M; Rechberger T
    Ginekol Pol; 2009 Jan; 80(1):47-53. PubMed ID: 19323060
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation.
    Paulsen T; Ree AH; Kaern J; Kjaerheim K; Bassarova A; Berner A; Haldorsen T; Tropé C; Nesland JM
    Eur J Gynaecol Oncol; 2007; 28(5):356-63. PubMed ID: 17966213
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (timp-1 and timp-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
    Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Improvement in the outcome of children with germ cell tumors.
    Lopes LF; Sonaglio V; Ribeiro KC; Schneider DT; de Camargo B
    Pediatr Blood Cancer; 2008 Feb; 50(2):250-3. PubMed ID: 17554793
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gelatinases and their tissue inhibitors in ovarian tumors; timp-1 is a predictive as well as a prognostic factor.
    Rauvala M; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin.
    Frazier AL; Grier HE; Green DM
    Med Pediatr Oncol; 1996 Aug; 27(2):69-73. PubMed ID: 8649322
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.